Semaglutide is a clinically proven GLP-1 (glucagon-like peptide-1) receptor agonist that mimics a naturally occurring hormone in the body responsible for regulating insulin secretion, glucose metabolism, and appetite
Williams to break down the rising wave of product liability lawsuits facing pharmaceutical manufacturers
Theyre commonly prescribed for type 2 diabetes and weight loss
Many patients use them on different times of day (for example, GHK-Cu in the morning and tretinoin/niacinamide at night) or on alternate nights, depending on skin tolerance
As these medications reduce overall energy intake, individuals are consuming fewer calories with estimates placing this reduction between 16 and 39%, or about 700 calories per day on average (Christensen et al., 2024)
Further research is necessary to enhance our understanding of these relationships and to investigate novel therapeutic interventions for individuals with vitamin B deficiencies and associated neuropsychiatric symptoms